Abstract
Qian HS, Li WJ, Dang YN, et al. Ten-day vonoprazan-amoxicillin dual therapy as a first-line treatment of Helicobacter pylori infection compared with bismuth-containing quadruple therapy. Am J Gastroenterol. 2023;118:627-634. 36729890.
MeSH terms
-
Amoxicillin / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Clarithromycin / therapeutic use
-
Drug Therapy, Combination
-
Helicobacter Infections* / drug therapy
-
Helicobacter pylori*
-
Humans
-
Proton Pump Inhibitors / therapeutic use
-
Treatment Outcome
Substances
-
Amoxicillin
-
Anti-Bacterial Agents
-
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
-
Proton Pump Inhibitors
-
Clarithromycin